Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Tetraspanin-decorated extracellular vesicle-mimetics as a novel adaptable reference material.

Lozano-Andrés E, Libregts SF, Toribio V, Royo F, Morales S, López-Martín S, Valés-Gómez M, Reyburn HT, Falcón-Pérez JM, Wauben MH, Soto M, Yáñez-Mó M.

J Extracell Vesicles. 2019 Mar 4;8(1):1573052. doi: 10.1080/20013078.2019.1573052. eCollection 2019.

2.

Impaired control of multiple viral infections in a family with complete IRF9 deficiency.

Bravo García-Morato M, Calvo Apalategi A, Bravo-Gallego LY, Blázquez Moreno A, Simón-Fuentes M, Garmendia JV, Méndez Echevarría A, Del Rosal Rabes T, Domínguez-Soto Á, López-Granados E, Reyburn HT, Rodríguez Pena R.

J Allergy Clin Immunol. 2019 Jul;144(1):309-312.e10. doi: 10.1016/j.jaci.2019.02.019. Epub 2019 Feb 28. No abstract available.

PMID:
30826365
3.

NKG2H-Expressing T Cells Negatively Regulate Immune Responses.

Dukovska D, Fernández-Soto D, Valés-Gómez M, Reyburn HT.

Front Immunol. 2018 Mar 1;9:390. doi: 10.3389/fimmu.2018.00390. eCollection 2018.

4.

New human combined immunodeficiency caused by interferon regulatory factor 4 (IRF4) deficiency inherited by uniparental isodisomy.

Bravo García-Morato M, Aracil Santos FJ, Briones AC, Blázquez Moreno A, Del Pozo Maté Á, Domínguez-Soto Á, Beato Merino MJ, Del Pino Molina L, Torres Canizales J, Marin AV, Vallespín García E, Feito Rodríguez M, Plaza López Sabando D, Jiménez-Reinoso A, Mozo Del Castillo Y, Sanz Santaeufemia FJ, de Lucas-Laguna R, Cárdenas PP, Casamayor Polo L, Coronel Díaz M, Valés-Gómez M, Roldán Santiago E, Ferreira Cerdán A, Nevado Blanco J, Corbí ÁL, Reyburn HT, Regueiro JR, López-Granados E, Rodríguez Pena R.

J Allergy Clin Immunol. 2018 May;141(5):1924-1927.e18. doi: 10.1016/j.jaci.2017.12.995. Epub 2018 Mar 2. No abstract available.

PMID:
29408330
5.

Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.

Ravenhall M, Campino S, Sepúlveda N, Manjurano A, Nadjm B, Mtove G, Wangai H, Maxwell C, Olomi R, Reyburn H, Drakeley CJ, Riley EM, Clark TG; MalariaGEN.

PLoS Genet. 2018 Jan 30;14(1):e1007172. doi: 10.1371/journal.pgen.1007172. eCollection 2018 Jan.

6.

Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.

López-Cobo S, Pieper N, Campos-Silva C, García-Cuesta EM, Reyburn HT, Paschen A, Valés-Gómez M.

Oncoimmunology. 2017 Nov 6;7(2):e1392426. doi: 10.1080/2162402X.2017.1392426. eCollection 2018.

7.

Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection.

Esteso G, Guerra S, Valés-Gómez M, Reyburn HT.

J Biol Chem. 2017 Dec 15;292(50):20472-20480. doi: 10.1074/jbc.M117.818393. Epub 2017 Oct 6.

8.

"It is good to take her early to the doctor" - mothers' understanding of childhood pneumonia symptoms and health care seeking in Kilimanjaro region, Tanzania.

Muro F, Meta J, Renju J, Mushi A, Mbakilwa H, Olomi R, Reyburn H, Hildenwall H.

BMC Int Health Hum Rights. 2017 Sep 22;17(1):27. doi: 10.1186/s12914-017-0135-1.

9.

Analysis of the recovery of CD247 expression in a PID patient: insights into the spontaneous repair of defective genes.

Blázquez-Moreno A, Pérez-Portilla A, Agúndez-Llaca M, Dukovska D, Valés-Gómez M, Aydogmus C, Ikinciogullari A, Regueiro JR, Reyburn HT.

Blood. 2017 Sep 7;130(10):1205-1208. doi: 10.1182/blood-2017-01-762864. Epub 2017 Jul 25.

10.

Transmembrane features governing Fc receptor CD16A assembly with CD16A signaling adaptor molecules.

Blázquez-Moreno A, Park S, Im W, Call MJ, Call ME, Reyburn HT.

Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):E5645-E5654. doi: 10.1073/pnas.1706483114. Epub 2017 Jun 26.

11.

Resistance to malaria through structural variation of red blood cell invasion receptors.

Leffler EM, Band G, Busby GBJ, Kivinen K, Le QS, Clarke GM, Bojang KA, Conway DJ, Jallow M, Sisay-Joof F, Bougouma EC, Mangano VD, Modiano D, Sirima SB, Achidi E, Apinjoh TO, Marsh K, Ndila CM, Peshu N, Williams TN, Drakeley C, Manjurano A, Reyburn H, Riley E, Kachala D, Molyneux M, Nyirongo V, Taylor T, Thornton N, Tilley L, Grimsley S, Drury E, Stalker J, Cornelius V, Hubbart C, Jeffreys AE, Rowlands K, Rockett KA, Spencer CCA, Kwiatkowski DP; Malaria Genomic Epidemiology Network.

Science. 2017 Jun 16;356(6343). pii: eaam6393. doi: 10.1126/science.aam6393. Epub 2017 May 18.

12.

Use of Lentiviral Particles As a Cell Membrane-Based mFasL Delivery System for In Vivo Treatment of Inflammatory Arthritis.

Rodríguez-Frade JM, Guedán A, Lucas P, Martínez-Muñoz L, Villares R, Criado G, Balomenos D, Reyburn HT, Mellado M.

Front Immunol. 2017 Apr 21;8:460. doi: 10.3389/fimmu.2017.00460. eCollection 2017.

13.

Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings.

Hopkins H, Bruxvoort KJ, Cairns ME, Chandler CI, Leurent B, Ansah EK, Baiden F, Baltzell KA, Björkman A, Burchett HE, Clarke SE, DiLiberto DD, Elfving K, Goodman C, Hansen KS, Kachur SP, Lal S, Lalloo DG, Leslie T, Magnussen P, Jefferies LM, Mårtensson A, Mayan I, Mbonye AK, Msellem MI, Onwujekwe OE, Owusu-Agyei S, Reyburn H, Rowland MW, Shakely D, Vestergaard LS, Webster J, Wiseman VL, Yeung S, Schellenberg D, Staedke SG, Whitty CJ.

BMJ. 2017 Mar 29;356:j1054. doi: 10.1136/bmj.j1054. Erratum in: BMJ. 2017 Jun 29;357:j3168.

14.

Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.

Clarke GM, Rockett K, Kivinen K, Hubbart C, Jeffreys AE, Rowlands K, Jallow M, Conway DJ, Bojang KA, Pinder M, Usen S, Sisay-Joof F, Sirugo G, Toure O, Thera MA, Konate S, Sissoko S, Niangaly A, Poudiougou B, Mangano VD, Bougouma EC, Sirima SB, Modiano D, Amenga-Etego LN, Ghansah A, Koram KA, Wilson MD, Enimil A, Evans J, Amodu OK, Olaniyan S, Apinjoh T, Mugri R, Ndi A, Ndila CM, Uyoga S, Macharia A, Peshu N, Williams TN, Manjurano A, Sepúlveda N, Clark TG, Riley E, Drakeley C, Reyburn H, Nyirongo V, Kachala D, Molyneux M, Dunstan SJ, Phu NH, Quyen NN, Thai CQ, Hien TT, Manning L, Laman M, Siba P, Karunajeewa H, Allen S, Allen A, Davis TM, Michon P, Mueller I, Molloy SF, Campino S, Kerasidou A, Cornelius VJ, Hart L, Shah SS, Band G, Spencer CC, Agbenyega T, Achidi E, Doumbo OK, Farrar J, Marsh K, Taylor T, Kwiatkowski DP; MalariaGEN Consortium.

Elife. 2017 Jan 9;6. pii: e15085. doi: 10.7554/eLife.15085.

15.

Point-of-care assessment of C-reactive protein and white blood cell count to identify bacterial aetiologies in malaria-negative paediatric fevers in Tanzania.

Hildenwall H, Muro F, Jansson J, Mtove G, Reyburn H, Amos B.

Trop Med Int Health. 2017 Mar;22(3):286-293. doi: 10.1111/tmi.12823. Epub 2016 Dec 28.

16.

Correction for Royo et al., Differential Induction of Apoptosis, Interferon Signaling, and Phagocytosis in Macrophages Infected with a Panel of Attenuated and Nonattenuated Poxviruses.

Royo S, Sainz B Jr, Hernández-Jiménez E, Reyburn H, López-Collazo E, Guerra S.

J Virol. 2016 Nov 28;90(24):11281. Print 2016 Dec 15. No abstract available.

17.

Variability of respiratory rate measurements in children suspected with non-severe pneumonia in north-east Tanzania.

Muro F, Mosha N, Hildenwall H, Mtei F, Harrison N, Schellenberg D, Olomi R, Reyburn H, Todd J.

Trop Med Int Health. 2017 Feb;22(2):139-147. doi: 10.1111/tmi.12814. Epub 2016 Dec 12.

18.

Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247.

Marin AV, Jiménez-Reinoso A, Briones AC, Muñoz-Ruiz M, Aydogmus C, Pasick LJ, Couso J, Mazariegos MS, Alvarez-Prado AF, Blázquez-Moreno A, Cipe FE, Haskologlu S, Dogu F, Morín M, Moreno-Pelayo MA, García-Sánchez F, Gil-Herrera J, Fernández-Malavé E, Reyburn HT, Ramiro AR, Ikinciogullari A, Recio MJ, Regueiro JR, Garcillán B.

J Allergy Clin Immunol. 2017 Jan;139(1):347-349.e8. doi: 10.1016/j.jaci.2016.06.020. Epub 2016 Aug 21. No abstract available.

PMID:
27555457
19.

Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids.

Oliveira-Rodríguez M, López-Cobo S, Reyburn HT, Costa-García A, López-Martín S, Yáñez-Mó M, Cernuda-Morollón E, Paschen A, Valés-Gómez M, Blanco-López MC.

J Extracell Vesicles. 2016 Aug 12;5:31803. doi: 10.3402/jev.v5.31803. eCollection 2016.

20.

Correction for Royo et al., Differential Induction of Apoptosis, Interferon Signaling, and Phagocytosis in Macrophages Infected with a Panel of Attenuated and Nonattenuated Poxviruses.

Royo S, Sainz B Jr, Hernández-Jiménez E, Reyburn H, López-Collazo E, Guerra S.

J Virol. 2016 May 12;90(11):5530-5531. doi: 10.1128/JVI.00485-16. Print 2016 Jun 1. No abstract available.

21.

The feasibility and acceptability of screening for hypertension in private drug retail outlets: a pilot study in Mwanza region, Tanzania.

Michael D, Kezakubi D, Juma A, Todd J, Reyburn H, Renju J.

Int Health. 2016 Sep;8(5):360-6. doi: 10.1093/inthealth/ihw023. Epub 2016 May 11.

22.

Ionomycin Treatment Renders NK Cells Hyporesponsive.

Romera-Cárdenas G, Thomas LM, Lopez-Cobo S, García-Cuesta EM, Long EO, Reyburn HT.

PLoS One. 2016 Mar 23;11(3):e0150998. doi: 10.1371/journal.pone.0150998. eCollection 2016.

23.

Monitoring patient care through health facility exit interviews: an assessment of the Hawthorne effect in a trial of adherence to malaria treatment guidelines in Tanzania.

Leurent B, Reyburn H, Muro F, Mbakilwa H, Schellenberg D.

BMC Infect Dis. 2016 Feb 3;16:59. doi: 10.1186/s12879-016-1362-0.

24.

Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.

Hart PJ, O'Shaughnessy CM, Siggins MK, Bobat S, Kingsley RA, Goulding DA, Crump JA, Reyburn H, Micoli F, Dougan G, Cunningham AF, MacLennan CA.

PLoS One. 2016 Jan 7;11(1):e0145945. doi: 10.1371/journal.pone.0145945. eCollection 2016.

25.

A short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation.

Fernández-Messina L, Reyburn HT, Valés-Gómez M.

Immunol Cell Biol. 2016 May;94(5):479-85. doi: 10.1038/icb.2016.2. Epub 2016 Jan 6.

PMID:
26732147
26.
27.

Causes of non-malarial febrile illness in outpatients in Tanzania.

Hildenwall H, Amos B, Mtove G, Muro F, Cederlund K, Reyburn H.

Trop Med Int Health. 2016 Jan;21(1):149-156. doi: 10.1111/tmi.12635. Epub 2015 Nov 26.

28.

Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient.

Valés-Gómez M, Esteso G, Aydogmus C, Blázquez-Moreno A, Marín AV, Briones AC, Garcillán B, García-Cuesta EM, López Cobo S, Haskologlu S, Moraru M, Cipe F, Dobbs K, Dogu F, Parolini S, Notarangelo LD, Vilches C, Recio MJ, Regueiro JR, Ikinciogullari A, Reyburn HT.

J Allergy Clin Immunol. 2016 Mar;137(3):942-5.e4. doi: 10.1016/j.jaci.2015.07.051. Epub 2015 Nov 2. No abstract available.

PMID:
26542031
29.

Use of functional genomics to understand replication deficient poxvirus-host interactions.

Fernández-Escobar M, Baldanta S, Reyburn H, Guerra S.

Virus Res. 2016 May 2;216:1-15. doi: 10.1016/j.virusres.2015.10.008. Epub 2015 Oct 28. Review.

PMID:
26519757
30.

Bringing the state into the clinic? Incorporating the rapid diagnostic test for malaria into routine practice in Tanzanian primary healthcare facilities.

Hutchinson E, Reyburn H, Hamlyn E, Long K, Meta J, Mbakilwa H, Chandler C.

Glob Public Health. 2017 Sep;12(9):1077-1091. doi: 10.1080/17441692.2015.1091025. Epub 2015 Oct 12.

31.

Genetic determinants of anti-malarial acquired immunity in a large multi-centre study.

Shelton JM, Corran P, Risley P, Silva N, Hubbart C, Jeffreys A, Rowlands K, Craik R, Cornelius V, Hensmann M, Molloy S, Sepulveda N, Clark TG, Band G, Clarke GM, Spencer CC, Kerasidou A, Campino S, Auburn S, Tall A, Ly AB, Mercereau-Puijalon O, Sakuntabhai A, Djimdé A, Maiga B, Touré O, Doumbo OK, Dolo A, Troye-Blomberg M, Mangano VD, Verra F, Modiano D, Bougouma E, Sirima SB, Ibrahim M, Hussain A, Eid N, Elzein A, Mohammed H, Elhassan A, Elhassan I, Williams TN, Ndila C, Macharia A, Marsh K, Manjurano A, Reyburn H, Lemnge M, Ishengoma D, Carter R, Karunaweera N, Fernando D, Dewasurendra R, Drakeley CJ, Riley EM, Kwiatkowski DP, Rockett KA; MalariaGEN Consortium.

Malar J. 2015 Aug 28;14:333. doi: 10.1186/s12936-015-0833-x.

32.

Predicting mortality in sick African children: the FEAST Paediatric Emergency Triage (PET) Score.

George EC, Walker AS, Kiguli S, Olupot-Olupot P, Opoka RO, Engoru C, Akech SO, Nyeko R, Mtove G, Reyburn H, Berkley JA, Mpoya A, Levin M, Crawley J, Gibb DM, Maitland K, Babiker AG.

BMC Med. 2015 Jul 31;13:174. doi: 10.1186/s12916-015-0407-3.

33.

NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation.

Moraru M, Black LE, Muntasell A, Portero F, López-Botet M, Reyburn HT, Pandey JP, Vilches C.

J Immunol. 2015 Aug 15;195(4):1676-84. doi: 10.4049/jimmunol.1500872. Epub 2015 Jul 15.

34.

Etiology of Severe Febrile Illness in Low- and Middle-Income Countries: A Systematic Review.

Prasad N, Murdoch DR, Reyburn H, Crump JA.

PLoS One. 2015 Jun 30;10(6):e0127962. doi: 10.1371/journal.pone.0127962. eCollection 2015. Review.

35.

NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.

García-Cuesta EM, López-Cobo S, Álvarez-Maestro M, Esteso G, Romera-Cárdenas G, Rey M, Cassady-Cain RL, Linares A, Valés-Gómez A, Reyburn HT, Martínez-Piñeiro L, Valés-Gómez M.

Front Immunol. 2015 Jun 8;6:284. doi: 10.3389/fimmu.2015.00284. eCollection 2015.

36.

Prescriber and patient-oriented behavioural interventions to improve use of malaria rapid diagnostic tests in Tanzania: facility-based cluster randomised trial.

Cundill B, Mbakilwa H, Chandler CI, Mtove G, Mtei F, Willetts A, Foster E, Muro F, Mwinyishehe R, Mandike R, Olomi R, Whitty CJ, Reyburn H.

BMC Med. 2015 May 15;13:118. doi: 10.1186/s12916-015-0346-z.

37.

Transfer of the human NKG2D ligands UL16 binding proteins (ULBP) 1-3 is related to lytic granule release and leads to ligand retransfer and killing of ULBP-recipient natural killer cells.

López-Cobo S, Romera-Cárdenas G, García-Cuesta EM, Reyburn HT, Valés-Gómez M.

Immunology. 2015 Sep;146(1):70-80. doi: 10.1111/imm.12482. Epub 2015 Jun 25.

38.

USP38, FREM3, SDC1, DDC, and LOC727982 Gene Polymorphisms and Differential Susceptibility to Severe Malaria in Tanzania.

Manjurano A, Sepúlveda N, Nadjm B, Mtove G, Wangai H, Maxwell C, Olomi R, Reyburn H, Drakeley CJ, Riley EM, Clark TG; in Collaboration With MalariaGEN.

J Infect Dis. 2015 Oct 1;212(7):1129-39. doi: 10.1093/infdis/jiv192. Epub 2015 Mar 24.

39.

Effect of context on respiratory rate measurement in identifying non-severe pneumonia in African children.

Muro F, Mtove G, Mosha N, Wangai H, Harrison N, Hildenwall H, Schellenberg D, Todd J, Olomi R, Reyburn H.

Trop Med Int Health. 2015 Jun;20(6):757-65. doi: 10.1111/tmi.12492. Epub 2015 Mar 27.

40.

African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania.

Manjurano A, Sepulveda N, Nadjm B, Mtove G, Wangai H, Maxwell C, Olomi R, Reyburn H, Riley EM, Drakeley CJ, Clark TG; MalariaGEN Consortium.

PLoS Genet. 2015 Feb 11;11(2):e1004960. doi: 10.1371/journal.pgen.1004960. eCollection 2015 Feb.

41.

Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness.

Kiguli S, Maitland K, George EC, Olupot-Olupot P, Opoka RO, Engoru C, Akech SO, Nyeko R, Mtove G, Reyburn H, Levin M, Babiker AG, Gibb DM, Crawley J.

BMC Med. 2015 Feb 2;13:21. doi: 10.1186/s12916-014-0246-7.

42.

Gradual acquisition of immunity to severe malaria with increasing exposure.

Griffin JT, Hollingsworth TD, Reyburn H, Drakeley CJ, Riley EM, Ghani AC.

Proc Biol Sci. 2015 Feb 22;282(1801):20142657. doi: 10.1098/rspb.2014.2657.

43.

Altered microRNA expression after infection with human cytomegalovirus leads to TIMP3 downregulation and increased shedding of metalloprotease substrates, including MICA.

Esteso G, Luzón E, Sarmiento E, Gómez-Caro R, Steinle A, Murphy G, Carbone J, Valés-Gómez M, Reyburn HT.

J Immunol. 2014 Aug 1;193(3):1344-52. doi: 10.4049/jimmunol.1303441. Epub 2014 Jun 27.

44.

The development of effective behaviour change interventions to support the use of malaria rapid diagnostic tests by Tanzanian clinicians.

Chandler CI, Meta J, Ponzo C, Nasuwa F, Kessy J, Mbakilwa H, Haaland A, Reyburn H.

Implement Sci. 2014 Jun 26;9:83. doi: 10.1186/1748-5908-9-83.

45.

The practice of 'doing' evaluation: lessons learned from nine complex intervention trials in action.

Reynolds J, DiLiberto D, Mangham-Jefferies L, Ansah EK, Lal S, Mbakilwa H, Bruxvoort K, Webster J, Vestergaard LS, Yeung S, Leslie T, Hutchinson E, Reyburn H, Lalloo DG, Schellenberg D, Cundill B, Staedke SG, Wiseman V, Goodman C, Chandler CI.

Implement Sci. 2014 Jun 17;9:75. doi: 10.1186/1748-5908-9-75.

46.

High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.

Matondo SI, Temba GS, Kavishe AA, Kauki JS, Kalinga A, van Zwetselaar M, Reyburn H, Kavishe RA.

Malar J. 2014 Apr 21;13:152. doi: 10.1186/1475-2875-13-152.

47.

Inpatient child mortality by travel time to hospital in a rural area of Tanzania.

Manongi R, Mtei F, Mtove G, Nadjm B, Muro F, Alegana V, Noor AM, Todd J, Reyburn H.

Trop Med Int Health. 2014 May;19(5):555-62. doi: 10.1111/tmi.12294. Epub 2014 Mar 24.

48.

Improving the consent process for neuroepidemiologic research in resource-poor settings.

Meta J, Nasuwa F, Mwendo E, Reyburn H, Bower JH.

Neurology. 2014 Mar 11;82(10):895-7. doi: 10.1212/WNL.0000000000000184. No abstract available.

49.

Differential induction of apoptosis, interferon signaling, and phagocytosis in macrophages infected with a panel of attenuated and nonattenuated poxviruses.

Royo S, Sainz B Jr, Hernández-Jiménez E, Reyburn H, López-Collazo E, Guerra S.

J Virol. 2014 May;88(10):5511-23. doi: 10.1128/JVI.00468-14. Epub 2014 Mar 5. Erratum in: J Virol. 2016 May 12;90(11):5530-1. J Virol. 2016 Nov 28;90(24):11281.

50.

Authors' reply to Southall.

Kiguli S, Akech SO, Mtove G, Opoka RO, Engoru C, Olupot-Olupot P, Nyeko R, Evans J, Crawley J, Prevatt N, Reyburn H, Levin M, George EC, South A, Babiker AG, Gibb DM, Maitland K.

BMJ. 2014 Feb 19;348:g1619. doi: 10.1136/bmj.g1619. No abstract available.

Supplemental Content

Loading ...
Support Center